Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bladder tumor markers: need, nature and application. 1. Nucleus-based markers

M M Kirollos1, S McDermott, R A Bradbrook

  • 1Urology Department, Torbay Hospital, South Devon Health Care Trust, UK.

International Urogynecology Journal and Pelvic Floor Dysfunction
|October 31, 1998
PubMed
Summary

Accurate diagnosis and management of bladder tumors rely on effective tumor markers. This review assesses older and newer urine-based bladder cancer tests for clinical utility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do images affect the triage status of pigmented lesion referrals.

Irish medical journal·2023
Same author

Can radiomic feature analysis differentiate adrenal metastases from lipid-poor adenomas on single-phase contrast-enhanced CT abdomen?

Clinical radiology·2022
Same author

The role of percutaneous CT-guided biopsy of an adrenal lesion in patients with known or suspected lung cancer.

Abdominal radiology (New York)·2020
Same author

Updates to the Canadian Notifiable Disease Surveillance System and its interactive website.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2019
Same author

Comparison of <sup>18</sup>F-FDG avidity at PET of benign and malignant pure ground-glass opacities: a paradox? Part II: artificial neural network integration of the PET/CT characteristics of ground-glass opacities to predict their likelihood of malignancy.

Clinical radiology·2019
Same author

Comparison of the <sup>18</sup>F-FDG avidity at PET of benign and malignant pure ground-glass opacities: a paradox?

Clinical radiology·2019

Area of Science:

  • Urology
  • Oncology
  • Biochemistry

Background:

  • Urothelial tumors, particularly bladder cancer, are prevalent and pose significant clinical challenges.
  • Management involves surveillance and treatment, with invasive disease requiring more aggressive approaches.
  • Reliable tumor markers are crucial for optimizing the benefit/risk ratio in diagnosis and treatment.

Purpose of the Study:

  • To review the clinical utility of various bladder cancer tumor markers.
  • To evaluate established methods like cytology and cytometry.
  • To assess the current status of novel nucleus-based tests.

Main Methods:

  • Literature review from a clinician's perspective.
  • Examination of diagnostic techniques for urothelial neoplasms.

Related Experiment Videos

  • Analysis of urine-based tumor markers.

    • Main Results:

    • Older techniques like cytology and cytometry have limitations.
    • Newer markers such as P53, telomerase, NMP22, and Ki67 show promise.
    • The effectiveness of these markers in clinical practice is under evaluation.

    Conclusions:

    • Improved bladder cancer tumor markers are needed for better patient management.
    • Novel nucleus-based tests warrant further investigation for clinical application.
    • The choice of diagnostic marker impacts treatment decisions and patient outcomes.